Privia Health Group, Inc. (NASDAQ: PRVA) is a Healthcare company (Medical - Healthcare Information Services) with a market capitalization of $3.2B. The Maz Rating grades it against the other companies in its sector.
Privia Health Group, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $24.99, Privia Health Group, Inc. trades at 89.8x trailing earnings, 1.3x sales and 3.9x book value, with an EV/EBITDA of 37.0. Over the last twelve months it generated about $2.4B of revenue and $36M of net income. It runs a gross margin of 10.5%, an operating margin of 2.1% and a net margin of 1.4%. It shows return on equity of 4.5%, return on invested capital of 3.6% and a free cash flow yield of 3.4%. On the balance sheet: a debt-to-equity ratio of 0.01 and a current ratio of 1.63. Over the past 52 weeks the share price ranged from $18.91 to $28.82, with a beta of 0.77.
Privia Health Group, Inc. does not currently pay a dividend.
22 Wall Street analyst ratings cover the stock: 20 Buy and 2 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.